121 related articles for article (PubMed ID: 15895884)
1. IL1beta+3953 exon 5 and IL-2 -330 promoter polymorphisms in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Florczak M; Gawronska Szklarz B; Herczyńska M
Clin Exp Rheumatol; 2005; 23(2):159-64. PubMed ID: 15895884
[TBL] [Abstract][Full Text] [Related]
2. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Wrzesniewska J; Florczak M; Gawronska-Szklarz B; Herczynska M
Rheumatol Int; 2005 Nov; 26(1):48-51. PubMed ID: 15660235
[TBL] [Abstract][Full Text] [Related]
3. IL-6 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Wrzesniewska J; Florczak M; Gawronska-Szklarz B; Herczynska M
Scand J Rheumatol; 2005; 34(2):109-13. PubMed ID: 16095005
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Florczak M; Ostanek L; Brzosko M; Brzosko I; Szklarz BG
Scand J Rheumatol; 2005; 34(1):22-6. PubMed ID: 15903021
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
[TBL] [Abstract][Full Text] [Related]
6. Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population.
Hussein YM; El-Shal AS; Rezk NA; Abdel Galil SM; Alzahrani SS
Cytokine; 2013 Mar; 61(3):849-55. PubMed ID: 23394902
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Szklarz BG; Herczynska M; Drozdzik M
Clin Rheumatol; 2005 Sep; 24(5):480-4. PubMed ID: 15915323
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients.
Paradowska-Gorycka A; Trefler J; Maciejewska-Stelmach J; Łacki JK
Int J Immunogenet; 2010 Aug; 37(4):225-31. PubMed ID: 20477882
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis.
Arman A; Yilmaz B; Coker A; Inanc N; Direskeneli H
Clin Exp Rheumatol; 2006; 24(6):643-8. PubMed ID: 17207379
[TBL] [Abstract][Full Text] [Related]
10. [The influence of IL-6 polymorphism on efficacy of treatment of rheumatoid arthritis patients with methotrexate and prednisone].
Pawlik A; Czerny B; Dabrowska-Zamojcin E; Górnik W; Poziomkowska I; Gawrońska-Szklarz B; Herczyńska M
Pol Arch Med Wewn; 2005 Sep; 114(3):843-7. PubMed ID: 16708557
[TBL] [Abstract][Full Text] [Related]
11. No association of polymorphisms of the CTLA-4 exon 1(+49) and promoter(-318) genes with rheumatoid arthritis in the Korean population.
Lee YH; Choi SJ; Ji JD; Song GG
Scand J Rheumatol; 2002; 31(5):266-70. PubMed ID: 12455815
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between -384 and 114 IL-2 gene polymorphisms and rheumatoid arthritis.
Fedetz M; Matesanz F; Cáliz R; Ferrer MA; Collado MD; Alcina A; Martín J
J Rheumatol; 2003 Mar; 30(3):435-7. PubMed ID: 12610796
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 gene (IL18) promoter polymorphisms in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Drozdzik M; Dziedziejko V; Safranow K; Herczynska M
Scand J Rheumatol; 2009; 38(3):159-65. PubMed ID: 19229765
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Czerny B; Gawronska-Szklarz B; Drozdzik M; Herczynska M
Tissue Antigens; 2006 May; 67(5):415-8. PubMed ID: 16671950
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis.
Cantagrel A; Navaux F; Loubet-Lescoulié P; Nourhashemi F; Enault G; Abbal M; Constantin A; Laroche M; Mazières B
Arthritis Rheum; 1999 Jun; 42(6):1093-100. PubMed ID: 10366101
[TBL] [Abstract][Full Text] [Related]
16. IL-6 promoter polymorphisms in rheumatoid arthritis.
Pascual M; Nieto A; Matarán L; Balsa A; Pascual-Salcedo D; Martín J
Genes Immun; 2000 Jun; 1(5):338-40. PubMed ID: 11196696
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis.
Huang CM; Tsai FJ; Wu JY; Wu MC
Scand J Rheumatol; 2001; 30(4):225-8. PubMed ID: 11578018
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis.
Lagha A; Zidi S; Stayoussef M; Gazouani E; Kochkar R; Kochbati S; Almawi WY; Yacoubi-Loueslati B
Pathol Biol (Paris); 2015 Sep; 63(4-5):179-84. PubMed ID: 26003199
[TBL] [Abstract][Full Text] [Related]
19. Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA).
Paradowska-Gorycka A; Wojtecka-Lukasik E; Trefler J; Wojciechowska B; Lacki JK; Maslinski S
Scand J Immunol; 2010 Aug; 72(2):134-41. PubMed ID: 20618772
[TBL] [Abstract][Full Text] [Related]
20. Possible genetic association between interleukin-1alpha gene polymorphism and the severity of chronic polyarthritis.
Jouvenne P; Chaudhary A; Buchs N; Giovine FS; Duff GW; Miossec P
Eur Cytokine Netw; 1999 Mar; 10(1):33-6. PubMed ID: 10210770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
